Physician profile
Del Sloneker
NPI 1871855650
$470.32
in general payments reported to CMS, 2019-2025
12 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.12 · 2023: $37.88 · 2024: $126 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $84.12 | 2022 | |
| Axogen | $67.61 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $62.67 | 2024-2025 | Libtayo |
| Polynovo North America LLC | $57.26 | 2023-2024 | Novosorb Btm |
| Sun Pharmaceutical Industries INC. | $47.44 | 2025 | |
| Caris Mpi, INC. | $27.12 | 2025 | Mi Cancer Seek |
| Kls-Martin L.P. | $24.47 | 2024 | |
| Biowound Solutions, INC. | $23.93 | 2025 | Bio-Connekt |
| Recordati_rare_diseases_inc. | $20.75 | 2024 | Sylvant |
| Inspire Medical Systems, INC. | $20.53 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $18.99 | 2024 | |
| Neurent Medical Limited | $15.43 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Del Sloneker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.